Skip to content

Exelixis EXEL Income Taxes Paid, Net

Income Taxes Paid, Net at other companies

Pfizer logo
PfizerPFE
Incyte logo
IncyteINCY
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
ALN
Alnylam PharmaceuticalsALNY
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
United Therapeutics logo
United TherapeuticsUTHR

Other financials

Income statement

See full
Revenue$610.8M+10.0%
Gross profit$590.9M+10.2%
Operating income$251.3M+34.5%
Net income$210.5M+31.9%
EPS (diluted)$0.79+43.6%

Balance sheet

See full
Cash & equivalents$226.2M+23.1%
Total debt$169.5M-9.4%
Total equity$1.9B-9.2%
Total assets$2.6B-8.6%

Cash flow

See full
Operating cash flow$251.8M+19.1%
CapEx$1.5M-48.9%
Free cash flow$250.3M+20.1%

Valuation

See full
Market cap$13.05B+10.1%
Enterprise value$12.99B+9.5%
P/E15.7×-2.8×
P/S5.5×+0.3×

Profitability

See full
Gross margin96.4%-0.3pp
Operating margin39.4%+6.3pp
Net margin35.1%+7.1pp
FCF margin38.6%+2.9pp

Returns & leverage

See full
Return on equity41%+10.8pp
Debt / equity0.1×0.0×
Current ratio3.3×-0.2×

Where this comes from

Reported directly by Exelixis in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxesPaidNet.

The official record: Exelixis’s 10-K, filed February 10, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exelixis's income taxes paid, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exelixis's income taxes paid, net?
Exelixis (EXEL) reported income taxes paid, net of $38.82M in Q4 2025.
How has Exelixis's income taxes paid, net changed year-over-year?
Exelixis's income taxes paid, net decreased by 8.9% year-over-year, from $42.62M to $38.82M.
What is the long-term trend for Exelixis's income taxes paid, net?
Over 4 years (2021 to 2025), Exelixis's income taxes paid, net has grown at a 86.1% compound annual growth rate (CAGR), from $12.96M to $155.3M.